Overall rank by patents
#1,297
Across all tracked assignees
USPTO PatentsView assignee record - 326 granted patents across 4 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
Klemm holds 326 US patents across 4 technology areas, rank #1,297 of 50,000 tracked assignees.
Klemm + SOHN Gmbh & Co. KG has been granted 326 US utility patents between 2015 and 2025, placing Klemm + SOHN Gmbh & Co. KG at rank #1,297 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.8 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a Foreign Corporation, Klemm + SOHN Gmbh & Co. KG is one of the more focused assignees in the PatentsView dataset. By volume, Klemm sits between Medimmune Limited (327 patents, rank #1,293) and Sumitomo Riko Company Limited (326 patents, rank #1,301) - the closest US assignees by grant volume. The composite Innovation Score of 33.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 147 grants, compared with 179 in the 2015–2019 window, a -18% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Klemm + SOHN Gmbh & Co. KG's 1.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Klemm + SOHN Gmbh & Co. KG against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MedImmune Limited
327 patents
University of Houston System
327 patents
Bayer Pharma Aktiengesellschaft
326 patents
HANGZHOU HIKVISION DIGITAL TECHNOLOGY CO., LTD.
326 patents
Littelfuse, Inc.
326 patents
NINGDE AMPEREX TECHNOLOGY LIMITED
326 patents
SICK AG
326 patents
Sumitomo Riko Company Limited
326 patents
KLEMM + SOHN GMBH & CO. KG
326 patents
What this shows Klemm holds 326 patents at rank #1,297, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,297 in granted patent volume.
Other assignees with the most granted patents in Klemm's primary technology class.
Klemm's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 57% higher than 43% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 25 | 7.7% |
| 2016 | 44 | 13.5% |
| 2017 | 40 | 12.3% |
| 2018 | 25 | 7.7% |
| 2019 | 45 | 13.8% |
| 2020 | 24 | 7.4% |
| 2021 | 33 | 10.1% |
| 2022 | 40 | 12.3% |
| 2023 | 14 | 4.3% |
| 2024 | 20 | 6.1% |
| 2025 | 16 | 4.9% |
Top 4 of 4 technology areas
Overall rank by patents
#1,297
Across all tracked assignees
33.0 out of 100
How to use this portfolio
Klemm's 326 grants land it in the top 57% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.